FDA Inspection 1178423 — Southern California Reproductive Center Medical Group PC
The FDA completed an inspection of Southern California Reproductive Center Medical Group PC on August 15, 2022 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 15, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Beverly Hills, CA (United States)